| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 39.74▲ | 39.67▲ | 39.73▲ | 39.62▲ | 38.87▲ |
| MA10 | 39.72▲ | 39.72▲ | 39.73▲ | 39.79▲ | 40.75▼ |
| MA20 | 39.65▲ | 39.73▲ | 39.57▲ | 38.71▲ | 39.09▲ |
| MA50 | 39.70▲ | 39.52▲ | 39.69▲ | 40.42▼ | N/A |
| MA100 | 39.69▲ | 39.66▲ | 39.12▲ | 38.76▲ | N/A |
| MA200 | 39.53▲ | 39.00▲ | 39.07▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.021▲ | -0.007▼ | 0.028▲ | 0.225▲ | -0.356▼ |
| RSI | 60.827▲ | 56.467▲ | 54.890▲ | 52.879▲ | 53.666▲ |
| STOCH | 77.837 | 47.814 | 63.837 | 67.417 | 40.202 |
| WILL %R | 0.000▲ | -17.391▲ | -8.290▲ | -22.312▲ | -52.278 |
| CCI | 103.779▲ | 31.483 | 62.569 | 48.958 | -13.799 |
|
Friday, May 17, 2024 02:24 PM
The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021.
|
|
Friday, May 17, 2024 12:03 PM
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The three top performing stocks discussed below have appreciated in value by ...
|
|
Friday, May 17, 2024 09:00 AM
Eli Lilly and Company (NYSE: LLY) today announced that Alonzo Weems, executive vice president of enterprise risk management and chief ethics and compliance officer, and a member of Lilly's ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/05/24 | 39.99 | 39.99 | 39.43 | 39.80 | 191,342 |
| 16/05/24 | 39.31 | 39.905 | 38.945 | 39.88 | 273,331 |
| 15/05/24 | 39.70 | 39.73 | 39.17 | 39.49 | 202,771 |
| 14/05/24 | 39.63 | 39.86 | 39.12 | 39.46 | 179,345 |
| 13/05/24 | 40.53 | 40.63 | 39.34 | 39.45 | 140,866 |
| 10/05/24 | 39.665 | 40.60 | 39.39 | 40.58 | 216,449 |
| 09/05/24 | 39.67 | 40.28 | 39.35 | 40.23 | 250,270 |
| 08/05/24 | 40.11 | 40.11 | 39.3125 | 39.65 | 195,942 |
| 07/05/24 | 39.52 | 40.39 | 39.41 | 39.85 | 219,492 |
| 06/05/24 | 39.24 | 39.665 | 38.90 | 39.47 | 228,623 |
|
|
||||
|
|
||||
|
|